Maravai LifeSciences Holdings Inc (MRVI)

42.98 +0.98  +2.33% NASDAQ Oct 25, 12:17 USD

Maravai LifeSciences Holdings Cash from Operations (TTM):

335.41M for June 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 335.41M
March 31, 2021 181.19M
Dec. 31, 2020 152.19M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Benchmarks

BioCryst Pharmaceuticals Inc -169.32M
Agios Pharmaceuticals Inc -355.65M
Sage Therapeutics Inc 708.10M

Cash from Operations (TTM) Range, Past 5 Years

Minimum 152.19M Dec 2020
Maximum 335.41M Jun 2021
Average 222.93M


Top Biotech Stocks for Q4 2021
Yahoo 09/20 14:57 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.